MedPath

Memorial Sloan Kettering Cancer Center

Memorial Sloan Kettering Cancer Center logo
🇺🇸United States
Ownership
Private
Established
1884-01-01
Employees
10K
Market Cap
-
Website
http://www.mskcc.org

Spanish Translation of the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)

Completed
Conditions
Cancer
Interventions
Behavioral: questionnaire administration followed by cognitive interviews
First Posted Date
2011-09-19
Last Posted Date
2017-05-23
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Target Recruit Count
112
Registration Number
NCT01436240
Locations
🇺🇸

University of Miami, Miami, Florida, United States

🇺🇸

Md Anderson Cancer Center, Houston, Texas, United States

🇺🇸

Ralph Lauren Center for Cancer Care and Prevention, New York, New York, United States

and more 3 locations

In Vitro Expanded Allogeneic Epstein-Barr Virus Specific Cytotoxic T-Lymphocytes (EBV-CTLs) Genetically Targeted to the CD19 Antigen in B-cell Malignancies

Phase 1
Active, not recruiting
Conditions
Acute Lymphocytic Leukemia
Lymphoma
Interventions
Biological: Biological/Genetically Modified T cells
Drug: Cyclophosphamide-based chemotherapy
First Posted Date
2011-09-08
Last Posted Date
2024-12-04
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Target Recruit Count
19
Registration Number
NCT01430390
Locations
🇺🇸

Memorial Sloan Kettering Cancer Center, New York, New York, United States

The Reproducibility Of Diffusion Weighted Magnetic Resonance Imaging For Neuroendocrine Tumor Liver Metastases

Completed
Conditions
Gastro-enteropancreatic Neuroendocrine Tumor
Secondary Malignant Neoplasm of Liver
Interventions
Other: magnetic resonance imaging (MRI)
First Posted Date
2011-08-26
Last Posted Date
2023-01-23
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Target Recruit Count
20
Registration Number
NCT01423734
Locations
🇺🇸

Memorial Sloan Kettering Cancer Center, New York, New York, United States

Humanized 3F8 Monoclonal Antibody (Hu3F8) in Patients With High-Risk Neuroblastoma and GD2-Positive Tumors

Phase 1
Completed
Conditions
Neuroblastoma
Interventions
Biological: Humanized 3F8 Monoclonal Antibody (Hu3F8)
First Posted Date
2011-08-18
Last Posted Date
2023-08-04
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Target Recruit Count
68
Registration Number
NCT01419834
Locations
🇺🇸

Memorial Sloan Kettering Cancer Center, New York, New York, United States

Gemcitabine and Docetaxel in Combination With Pazopanib (Gem/Doce/Pzb) for the Neoadjuvant Treatment of Soft Tissue Sarcoma (STS)

Phase 1
Terminated
Conditions
Leiomyosarcoma
Malignant Peripheral Nerve Sheath Tumor
Histiocytoma/Undifferentiated Pleomorphic Sarcoma
Sarcoma
Malignant Fibrous
Interventions
First Posted Date
2011-08-16
Last Posted Date
2018-01-11
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Target Recruit Count
5
Registration Number
NCT01418001
Locations
🇺🇸

Washington University School of Medicine, Saint Louis, Missouri, United States

🇺🇸

Memorial Sloan-Kettering Cancer Center, New York, New York, United States

🇺🇸

UCLA, Los Angeles, California, United States

and more 1 locations

Consolidation Therapy With Autologous T Cells Genetically Targeted to the B Cell Specific Antigen CD19 in Patients With Chronic Lymphocytic Leukemia Following Upfront Chemotherapy With Pentostatin, Cyclophosphamide and Rituximab

Phase 1
Completed
Conditions
Leukemia
Interventions
Drug: cyclophosphamide
Biological: modified T cells
First Posted Date
2011-08-15
Last Posted Date
2019-01-11
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Target Recruit Count
13
Registration Number
NCT01416974
Locations
🇺🇸

Memorial Sloan Kettering Cancer Center, New York, New York, United States

Fractionated Stem Cell Infusions in Myeloma Patients Undergoing Autologous Stem Cell Transplant

Not Applicable
Completed
Conditions
Multiple Myeloma
Interventions
Procedure: Fractionated Stem Cell Infusions
First Posted Date
2011-08-12
Last Posted Date
2016-04-29
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Target Recruit Count
26
Registration Number
NCT01416246
Locations
🇺🇸

Memorial Sloan-Kettering Cancer Center, New York, New York, United States

Measuring Patient Expectations for Thyroid Surgery

Active, not recruiting
Conditions
Thyroid Cancer
Interventions
Behavioral: patient interviews
Behavioral: CITSAV survey
First Posted Date
2011-08-09
Last Posted Date
2023-10-23
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Target Recruit Count
138
Registration Number
NCT01412762
Locations
🇺🇸

Memorial Sloan Kettering Cancer Center, New York, New York, United States

Trial of Modifications to Radical Prostatectomy

Phase 3
Active, not recruiting
Conditions
Prostate Cancer
Interventions
Procedure: Transverse versus vertical closure
Drug: Hemostatic Agent
Procedure: Lymph node template
Drug: antibiotic prophylaxis
First Posted Date
2011-08-02
Last Posted Date
2024-08-14
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Target Recruit Count
3204
Registration Number
NCT01407263
Locations
🇺🇸

Memorial Sloan Kettering Cancer Center @ Nassau (Consent only), Uniondale, New York, United States

🇺🇸

Memorial Sloan Kettering Westchester, Harrison, New York, United States

🇺🇸

Memorial Sloan Kettering Cancer Center, New York, New York, United States

and more 2 locations

Combined Tretinoin and Arsenic Trioxide for Patients With Newly Diagnosed Acute Promyelocytic Leukemia Followed by Risk-Adapted Postremission Therapy

Phase 2
Completed
Conditions
Acute Promyelocytic Leukemia
Interventions
First Posted Date
2011-07-28
Last Posted Date
2021-11-30
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Target Recruit Count
17
Registration Number
NCT01404949
Locations
🇺🇸

Memorial Sloan Kettering Cancer Center, New York, New York, United States

🇺🇸

New York Presbyterian Hospital-Weill Medical College of Cornell University, New York, New York, United States

🇺🇸

Memorial Sloan Kettering Westchester, Harrison, New York, United States

and more 9 locations
© Copyright 2025. All Rights Reserved by MedPath